文献速递肺外科先天性心脏病外科心外重症与机械循环支持

活体供者肺段移植用于儿科患者

Living-donor segmental lung transplantation for pediatric patients.
PubMed 文献 · J Thorac Cardiovasc Surg · 2022-08-06

该研究评估了2009年8月至2021年5月间6例危重儿科患者接受活体供者肺段移植的结局。所有患者均在体外循环下接受双肺移植,植入的9个肺段移植物中7个再灌注后功能良好,2个旋转的S6段移植物出现充血。院内死亡1例(术后14天,脓毒症),晚期死亡1例(术后9年,脑白质病),其余4例存活。

要点

  • 活体供者肺段移植对胸腔过小无法植入成人下叶的小儿患者技术上困难但可行。
  • 9个植入肺段中7个再灌注后功能良好,2个旋转S6段移植物充血,1例需移除移植物,1例静脉修复成功。
  • 6例患者中院内死亡1例(14天,脓毒症),晚期死亡1例(9年,脑白质病),4例存活。

核心结论

  • 活体供者肺段移植对胸腔过小无法植入成人下叶的小儿患者是技术上困难但可行的手术,结局可接受。

研究设计与样本

  • 2009年8月至2021年5月间,对6例危重儿科患者实施活体供者肺段移植,其中1例仅用呼吸机,另1例用呼吸机和体外膜肺氧合(ECMO)。
  • 患者4男2女,中位年龄7岁(范围4-15岁),中位身高112.7 cm(范围95-125.2 cm);诊断包括异基因造血干细胞移植并发症(n=4)和肺纤维化(n=2)。
  • 所有患者均在体外循环下接受双肺移植;3例植入一个基底段和一个下叶,另3例植入一个基底段和一个S6段;2例将右侧S6段移植物水平旋转180°后作为左肺植入。

主要发现

  • 植入的9个肺段移植物中,7个再灌注后功能良好。
  • 2个旋转的S6段移植物出现充血,其中1例需移除移植物,另1例静脉修复成功。
  • 院内死亡1例(14天)因脓毒症,晚期死亡1例(9年)因脑白质病;其余4例目前存活,分别为9个月、10个月、1.3年和1.9年。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The preset study evaluated the outcome of living-donor segmental lung transplantation for pediatric patients. METHODS: Between August 2009 and May 2021, we performed living-donor segmental lung transplantation in 6 critically ill pediatric patients, including 1 patient on a ventilator alone and another patient on a ventilator and extracorporeal membrane oxygenation (ECMO). There were 4 male and 2 female patients, with a median age of 7 years (range, 4-15 years) and a median height of 112.7 cm (range, 95-125.2 cm). The diagnoses included complications of allogeneic hematopoietic stem cell transplantation (n = 4) and pulmonary fibrosis (n = 2). All patients received bilateral lung transplantation under cardiopulmonary bypass. A basal segment and a lower lobe were implanted in 3 patients, and a basal segment and an S6 segment were implanted in the other 3 patients. In 2 patients, the right S6 segmental graft was horizontally rotated 180° and implanted as the left lung. RESULTS: Among the 9 segmental grafts implanted, 7 functioned well after reperfusion. Two rotated S6 segmental grafts became congestive, with 1 requiring graft extraction and the other venous repair, which was successful. There was 1 hospital death (14 days) due to sepsis and 1 late death (9 years) due to leukoencephalopathy. The remaining 4 patients are currently alive at 9 months, 10 months, 1.3 years, and 1.9 years. CONCLUSIONS: Living-donor segmental lung transplantation was a technically difficult but feasible procedure with acceptable outcomes for small pediatric patients with chest cavities that were too small for adult lower lobe implantation.

来源:J Thorac Cardiovasc Surg,查看原文。版权归原作者所有。

引用

  1. Nakajima D, Tanaka S, Ikeda T, et al. Living-donor segmental lung transplantation for pediatric patients. J Thorac Cardiovasc Surg. 2022. PMID: 36088146. doi:10.1016/j.jtcvs.2022.07.031

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。